Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial

Prostate cancer (PCa) is the second most common non-dermatological cancer in men and is a growing public health problem. Castration-resistant disease (CRD) is the most advanced stage of the disease and is difficult to control. Patients with CRD may no longer accept conventional therapies as they are...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Guzman-Esquivel, José, Mendoza-Hernandez, Martha A., Tiburcio-Jimenez, Daniel, Avila-Zamora, Oscar N., Delgado-Enciso, Josuel, De-Leon-Zaragoza, Luis, Casarez-Price, Juan C., Rodriguez-Sanchez, Iram P., Martinez-Fierro, Margarita L., Meza-Robles, Carmen, Barocio-Acosta, Alejandro, Baltazar-Rodriguez, Luz M., Zaizar-Fregoso, Sergio A., Plata-Florenzano, Jorge E., Delgado-Enciso, Iván
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204620/
https://ncbi.nlm.nih.gov/pubmed/32391109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados